Welcome to our dedicated page for MICROVISION SEC filings (Ticker: MVIS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on MICROVISION's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into MICROVISION's regulatory disclosures and financial reporting.
Peterson Laura J. reported acquisition or exercise transactions in this Form 4 filing.
MicroVision, Inc. granted its director Laura J. Peterson 280,152 Restricted Stock Units (RSUs) on July 16, 2026. Each RSU represents a right to receive one share of common stock and will vest in four equal quarterly installments, becoming fully vested on the earlier of the first anniversary of the grant or the day prior to the 2027 Annual Meeting of Stockholders, contingent on her continued board service. Following this award, Peterson directly holds 280,152 RSUs.
Herbst Jeffrey A reported acquisition or exercise transactions in this Form 4 filing.
MicroVision, Inc. granted director Jeffrey A. Herbst 280,152 restricted stock units (RSUs), each representing one share of common stock. These RSUs vest in four equal quarterly installments until fully vested on the earlier of the first anniversary of the July 16, 2026 grant or the day before the 2027 annual stockholders meeting, contingent on his continued board service.
Carlile Robert Paul reported acquisition or exercise transactions in this Form 4 filing.
MicroVision, Inc. director Robert Paul Carlile received a grant of 280,152 Restricted Stock Units (RSUs) on July 16, 2026. Each RSU represents a contingent right to receive one share of MicroVision common stock. The RSUs vest in four equal quarterly installments until fully vested on the earlier of the first anniversary of the grant date or the day prior to MicroVision's 2027 Annual Meeting of Stockholders, subject to his continued board service. Following this grant, he directly holds 280,152 RSUs.
MicroVision, Inc. has filed a shelf registration statement that permits it to offer, from time to time after effectiveness, up to $50,000,000 of common stock, preferred stock, warrants and subscription rights through various transaction types, including underwritten, direct, and at-the-market offerings of common stock.
Net proceeds from any offerings are expected to be used for general corporate purposes, including working capital and capital expenditures. As of June 30, 2026, 350,250,363 common shares were outstanding out of 510,000,000 authorized, and the Nasdaq closing price was $0.38 per share on July 10, 2026.
MicroVision develops lidar-based perception solutions for automotive, industrial, and security & defense markets and has expanded its portfolio through acquisitions of assets from Ibeo, Scantinel Photonics, and Luminar’s lidar business. The company reports a history of significant losses and states that investments in its securities involve a high degree of risk.
MicroVision, Inc. held its annual shareholder meeting on July 10, 2026, with shareholders present in person or by proxy representing 214,190,090 shares, or 62% of common stock entitled to vote. All seven director nominees were elected, each receiving more votes "For" than "Withheld".
Shareholders approved the issuance of common shares related to senior secured convertible notes issued on February 23, 2026, for purposes of complying with Nasdaq rules. They also approved amendments to the certificate of incorporation authorizing the Board to implement a reverse stock split at a ratio between 1-for-5 and 1-for-15 and to reduce authorized shares to 150 million within one year of the meeting.
On an advisory basis, shareholders approved executive compensation and ratified Baker Tilly US, LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026.
MicroVision, Inc. furnished an update for investors by posting a CEO letter and detailed Q&A on its investor relations website. The materials address topics raised during the company’s June 25 virtual Business Update and Shareholder Q&A event and are attached as Exhibit 99.1.
The company states this information is provided under Regulation FD, is considered summary in nature, and should be read together with its other SEC filings and public announcements. The disclosure is furnished, not filed, and is not incorporated by reference into Securities Act registration statements.
MicroVision, Inc. filed a current report to alert investors that it has posted presentation slides from its June 25, 2026 virtual Business Update and Shareholder Q&A event on the investor relations section of its website. These slides are also attached as Exhibit 99.1.
The company states it may reuse or modify these slides in presentations to investors, analysts, and others throughout 2026. The information is being furnished under Regulation FD, not filed, meaning it is not subject to certain liability provisions and is not automatically incorporated into Securities Act registration statements.
MicroVision, Inc. proposes to register up to $42,000,000 of common stock for sale under an at-the-market program. The prospectus states sales may be made from time to time through Deutsche Bank Securities, Mizuho Securities USA and Craig-Hallum, acting as agents or principals, under a Sales Agreement amended June 12, 2026.
The filing illustrates an example that assumes issuance of 116,666,666 shares at an assumed price of $0.36 per share, which would result in up to 461,312,631 shares outstanding (based on 344,645,965 shares outstanding as of May 28, 2026). Net proceeds are intended for general corporate purposes.